Epidermal growth factor in NMU-induced mammary tumors in rats.
In this work we analyze the hypothesis that tumors induced by i.p. N-nitroso-N-methylurea injection express EGF-like peptides and EGF receptors which could be involved in the response to hormone manipulation. EGF receptors (EGFR) were determined in the purified membrane fraction of tumors from control and ovariectomized (OVX) animals and no significant differences were found in either maximal binding capacities (Q) or dissociation constants (Kd) between them. Neither did we observe differences between tumors that regressed (HR) or continued growing (HU) after ovariectomy. In order to test the ability of EGFR to trigger a biological response we measured the production of second messengers inositol triphosphates (IP3) and cAMP levels; we found that EGF increases IP3 production in a dose-dependent way, while cAMP levels were not affected. In addition, EGF was able to induce in vitro cell proliferation in a concentration-dependent manner when tested in primary cultures of tumor cells by the clonogenic soft agar technique. EGF/TGF-alpha activity was determined by a radioreceptor assay in tumor cytosols from control and OVX rats. Results showed a trend to lower values in tumors from OVX rats, but no differences between HR and HU tumors. A positive correlation was found between EGF/TGF-alpha activity and progesterone receptor maximal binding capacity. When we tested the action of estradiol and EGF added together to primary cultures of tumor cells we found an additive effect on cell proliferation. The study of steady state mRNA levels showed that E2 increases PgR and c-myc mRNA levels in HR but not in HU tumors. In conclusion, the autocrine loop EGFR-EGF/TGF-alpha present in all tumors is hormonally regulated, possibly by Pg, but is not related to the tumor response to ovariectomy.
Martin
G
G
Laboratorio de Radioisótopos, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina.
Cricco
G
G
Davio
C
C
Engel
N
N
Cocca
C
C
Rivera
E
E
Bergoc
R
R
D000818:Animals; D002273:Carcinogens; D000242:Cyclic AMP / Q000032:analysis; D004815:Epidermal Growth Factor / Q000032:analysis* / Q000494:pharmacology; D066246:ErbB Receptors / Q000032:analysis*; D005260:Female; D015674:Mammary Neoplasms, Animal / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D008770:Methylnitrosourea; D010052:Ovariectomy; D010716:Phosphatidylinositols / Q000378:metabolism; D016271:Proto-Oncogene Proteins c-myc / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D016211:Transforming Growth Factor alpha / Q000032:analysis
D002273:Carcinogens; D010716:Phosphatidylinositols; D016271:Proto-Oncogene Proteins c-myc; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D016211:Transforming Growth Factor alpha; D004815:Epidermal Growth Factor; D008770:Methylnitrosourea; D000242:Cyclic AMP; D066246:ErbB Receptors